Early Detection of PICC-related Deep Vein Thrombosis by US Surveillance: an Effective Approach for Secondary Prevention?
- Disease/Condition
- Central Venous Catheter Thrombosis
- Drug/Device/Intervention
- PICC-carrying patients
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- University of Turin, Italy
- Phase
- N/A
- Start date
- Jun 01, 2010
- End date
- Jun 01, 2012
- Enrollment
- 150 participants
early detection of PRDVT
Background: PICC-related thrombosis have shown a slightly different pattern of frequency and
 risk factors, compared with traditional CVC; because of the increasing diffusion of PICCs,
 they are becoming a somehow independent pathology, still under investigation; no
 pharmacological prevention has proved to be effective. Aim of this study is to estimate the
 cumulative incidence of thrombosis in a cohort of patients carrying a PICC-line CVC,
 monitored to allow an early detection and prevention of complications related to the presence
 of asymptomatic deep venous thrombosis, and to explore the role of several potential risk
 factors.
 
 Methods: in a prospective observational cohort we will enroll 150 consecutive patients having
 a PICC inserted by our team; clinical characteristics, comorbidities and main features of
 catheter positioning procedure will be registered; patients will be followed with clinical
 and echographic scheduled controls, weekly for the first month, then monthly; patients with
 PRDVT will be treated with LMWH and recontrolled weekly until removal of catheter
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT01779999
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT01779999 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Turin, Italy and is currently Completed. The study focuses on Central Venous Catheter Thrombosis. Target enrollment is 150 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.